NCT05831111 2025-09-30A Study of an Epstein-Barr Virus (EBV) Candidate Vaccine, mRNA-1195, in 18- to 55-Year-Old Healthy ParticipantsModernaTX, Inc.Phase 1 Active not recruiting482 enrolled